4Wang H,Lin X,Hao C,et al.A double-blind,placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients[J].Allergy,2006,61 (2):191-197.
5Gonzalez C,Cuesta C,Feijoo R,et al.A prospective safety-monitoring study of immunotherapy in mite-allergy patients with nassunits-standardized extract[J].Allergy,1997,52 (5):580-583.
6Blumberga G,Groes L,Haugaard L,et al.Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics[J].Allergy,2006,61 (7):843-848.
7Moreno C,Cuesta H J,Fernandez TL,et al.lmmunotherapy safety:a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases[J].2004,34(4):527-531.
8Nettis E,Giordano D,Pannofino A,et al.Safety of inhalant allergen immunotherapy with mass units-standardized extracts[J].2002,32(12):1745-1749.
9Cantani A,Arcese G,Lucenti P,et al.A three-year prospective study of specific immunotherapy to inhalant allergens:evidence of safety and efficacy in 300 children with allergic asthma[J].J Investig Allergol Clin Immunol,1997,7 (2):90-97.
10Akcakaya N,Hassanzadeh A,Camcioglu Y,et al.Local and systemic reactions during immunotherapy with adsorbed extracts of house dust mite in children[J].Ann Allergy Asthma Immunol,2000,85(4):317-32
